Mylan pulls Epipens in US on worries about Pfizer-made anaphylaxis jab

By Gareth Macdonald contact

- Last updated on GMT

iStock/Roel Smart
iStock/Roel Smart
Mylan has recalled batches of its EpiPen in the US over concerns the auto-injector device made by Pfizer’s Meridian Medical Technologies unit is faulty.

The US Food and Drug Administration (FDA) posted details​ of the recall on Friday, explaining Meridian had pulled 13 lots of the allergic reaction drug “due to the potential that these devices may contain a defective part that may result in the devices’ failure to activate​.”

The device issue – details of which have not been disclosed – has already seen Mylan recall EpiPens (epinephrine injection, USP) in several countries. The firm’s Meda unit was first to pull the product when it withdrew 499 units in Denmark last month​.

Since then the recall​ has been extended to Japan, Australia and New Zealand with more than 80,000 Epipens being pulled from pharmacy shelves.

Pfizer's Meridian Medical Technologies division makes the auto-injector device at its facility in St. Louis Missouri, US.

Mylan response

A Mylan spokeswoman told us "This recall is being conducted by Meridian Medical Technologies, a Pfizer company, as a result of the receipt of two previously disclosed reports outside of the US of failure to activate the device due to a potential defect in a supplier component. Both reports are related to the single lot that was previously recalled by Meridian.

"The incidence of the defect is extremely rare and testing and analysis across the potentially impacted lots has not identified any units with a defect. However, the recall is being expanded by Meridian to include additional lots as a precautionary measure out of an abundance of caution​."

The spokeswoman added that: "Testing and analysis across the potentially impacted lots has not identified any units with a defect​."

Related news

Show more

Related products

show more

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Flow Cytometry Services

Flow Cytometry Services

Q2 Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Local lab Data Management

Local lab Data Management

Q2 Solutions | 01-May-2020 | Data Sheet

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Related suppliers

Follow us

Products

View more

Webinars